AR032208A1 - Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis - Google Patents

Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis

Info

Publication number
AR032208A1
AR032208A1 ARP010106081A ARP010106081A AR032208A1 AR 032208 A1 AR032208 A1 AR 032208A1 AR P010106081 A ARP010106081 A AR P010106081A AR P010106081 A ARP010106081 A AR P010106081A AR 032208 A1 AR032208 A1 AR 032208A1
Authority
AR
Argentina
Prior art keywords
corticosteroids
treatment
pharmaceutical composition
use based
phymosis
Prior art date
Application number
ARP010106081A
Other languages
English (en)
Spanish (es)
Original Assignee
Apsen Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica S A filed Critical Apsen Farmaceutica S A
Publication of AR032208A1 publication Critical patent/AR032208A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP010106081A 2000-12-28 2001-12-27 Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis AR032208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Publications (1)

Publication Number Publication Date
AR032208A1 true AR032208A1 (es) 2003-10-29

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010106081A AR032208A1 (es) 2000-12-28 2001-12-27 Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis

Country Status (12)

Country Link
US (1) US7666858B2 (https=)
EP (1) EP1365766B1 (https=)
JP (1) JP5095907B2 (https=)
CN (1) CN1270719C (https=)
AR (1) AR032208A1 (https=)
AU (1) AU2002221365A1 (https=)
BR (1) BR0006556A (https=)
DE (1) DE60121047T2 (https=)
ES (1) ES2267671T3 (https=)
MX (1) MXPA03005813A (https=)
RU (1) RU2279893C2 (https=)
WO (1) WO2002053137A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
ES2520765T3 (es) * 2007-02-15 2014-11-11 Allergan, Inc. Uso de toxina botulínica para el tratamiento de hiperhidrosis
CA2802414C (en) * 2010-06-17 2018-01-09 Nitto Denko Corporation Agent for treating renal fibrosis
MX348420B (es) * 2010-07-20 2017-06-12 Halozyme Inc Efectos secundarios adversos asociados con la administracion de agentes anti-hialuronano y metodos para mejorar o prevenir los efectos secundarios.
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
CN1270719C (zh) 2006-08-23
HK1060850A1 (en) 2004-08-27
AU2002221365A1 (en) 2002-07-16
BR0006556A (pt) 2002-09-17
JP2004519451A (ja) 2004-07-02
DE60121047T2 (de) 2007-06-21
MXPA03005813A (es) 2005-02-14
WO2002053137A3 (en) 2003-04-24
RU2003119439A (ru) 2005-02-27
EP1365766A2 (en) 2003-12-03
EP1365766B1 (en) 2006-06-21
DE60121047D1 (de) 2006-08-03
WO2002053137A2 (en) 2002-07-11
JP5095907B2 (ja) 2012-12-12
RU2279893C2 (ru) 2006-07-20
US7666858B2 (en) 2010-02-23
US20040067922A1 (en) 2004-04-08
ES2267671T3 (es) 2007-03-16
CN1487833A (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
AR033808A1 (es) Una composicion topica de anestesia local y los parches y los envases que la contienen
DK0969813T3 (da) Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel
DZ3221A1 (fr) Nouvelles compositions estro-progestatives topiques a effet systemique
AR032208A1 (es) Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis
AR063201A1 (es) Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas
NO20003546L (no) Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ES2188656T3 (es) Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
DE50312034D1 (de) Liposomale glucocorticoide
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
BRPI0416275A (pt) métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
ES2171589T3 (es) Composiciones farmaceuticas solidas anhidras para uso vaginal.
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
AR051765A1 (es) Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas
ES2165948T3 (es) Modificacion cristalina termoestable y apta para almacenaje de n-metil-n-((1s)-1-fenil-2-((3s)-3-hidroxi-pirrolidin-1-il)-etil)-2,2-difenil-acetamida, y procedimiento para su obtencion.
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
AR031601A1 (es) Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
BRPI0518062A (pt) uso de um modulador de pde4, ou um sal, solvato, ou estereoisÈmero farmaceuticamente aceitável do mesmo, e, composição farmacêutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure